NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Publication Year 2022 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2022">2022</span>

471. How did the COVID-19 pandemic affect the education and employment of young people with disabilities?: findings from the Promoting Readiness of Minors in Supplemental Security Income (PROMISE) evaluation

Author(s):
Hill, Anna, (Health policy researcher), author
Patnaik, Ankita, author
Musse, Isabel, author
Publication:
Washington, DC : Mathematica, December 15, 2022
Subject(s):
Adolescent
COVID-19 -- economics
Disabled Persons -- education
Employment
Program Evaluation
Social Security
Vocational Education
Young Adult
United States

473. Promoting readiness of minors in Supplemental Security Income (PROMISE). Youth and family outcomes five years after enrollment

Author(s):
Patnaik, Ankita, author
Dale, Stacy, (Of Mathematica), author
Farid, Monica S., author
Harrati, Hamal, author
Hill, Anna, (Health policy researcher), author
Honeycutt, Todd, author
Katz, Karen, (Of Mathematica), author
Livermore, Gina, author
Musse, Isabel, author
Potamites, Liz, author
Sevak, Pervi, author
Publication:
Washington, DC : Mathematica, December 29, 2022
Subject(s):
Adolescent
Disabled Persons -- education
Employment
Family
Income -- statistics & numerical data
Vocational Education
Young Adult
United States

474. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Chu, Janet N., author
Moradi, Ashton, author
Herce-Hagiwara, Belen, author
Fahim, Shahariar Mohammed, author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Walton, Surrey M., author
Sarker, Jyotirmoy, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2022
Subject(s):
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Cost-Effectiveness Analysis
Genetic Therapy
Hemophilia A -- therapy
Hemophilia B -- therapy
United States

475. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update

Author(s):
Whittington, Melanie D., author
Campbell, Jonathan D., author
Richardson, Marina, author
Nhan, Emily, author
McKenna, Avery, author
Agboola, Foluso, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2022
Subject(s):
Ambulatory Care -- economics
Antiviral Agents -- economics
COVID-19 Drug Treatment
Drug Combinations
Drug Costs
Lactams
Leucine
Nitriles
Proline
Ritonavir
United States

476. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

Author(s):
Lee, Sei J., author
Beinfeld, Molly, author
Fluetsch, Noemi, author
Whittington, Melanie, D., author
Pearson, Steven D., author
Ollendorf, Daniel A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of University of Colorado Anschutz Medical Campus), author
Kwon, Sue, (Of University of Colorado Anschutz Medical Campus), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 22, 2022
Subject(s):
Immunoconjugates -- therapeutic use
Immunotherapy, Adoptive
Multiple Myeloma -- drug therapy
United States

477. Does schooling improve cognitive abilities at older ages?: causal evidence from nonparametric bounds

Author(s):
Amin, Vikesh, author
Behrman, Jere Richard, 1940- author
Fletcher, Jason, author
Flores, Carlos A., author
Flores-Lagunes, Alfonso, author
Kohler, Hans-Peter, author
Publication:
[Philadelphia, Pennsylvania] : Leonard Davis Institute of Health Economics : Population Aging Research Center, May 2022
Subject(s):
Aged
Cognition
Educational Status
Neuropsychological Tests
United States